In the second part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, details what the company’s ...

Marketed as BNT327, the PD-L1xVEGF-A bispecific antibody has the potential to become what the involved parties believe is a ...

A cross-sectional study explores how full-benefit dual-eligible beneficiaries differ across MA plans with differing levels of ...

In the first part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, explains how geospatial mapping ...

A Pharmaceutical Executive article explores how specialty pharmacy programs can significantly improve outcomes for patients with rare diseases—like cystic fibrosis—by providing faster access to ...

In the final part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, ...

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than ...

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug ...

An NEJM study explores how this loss—following Medicaid disenrollment—affects beneficiaries.

In the first part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, ...